Reboxetine mesylate

Pricing Availability Delivery Time Qty
Cat.No. 1982 - Reboxetine mesylate | C19H23NO3.CH3SO3H | CAS No. 98769-84-7
Description: Potent, selective noradrenalin uptake inhibitor; orally active
Chemical Name: (2R*)-2-[(R*)-(2-Ethoxyphenoxy)phenylmethyl]morpholine mesylate
Purity: ≥99% (HPLC)
Datasheet
Citations (7)
Reviews (1)
Literature

Biological Activity

Potent and selective inhibitor of noradrenalin uptake (Ki values are 1.1, 129 and > 10000 nM for rat NET, SERT and DAT respectively). Displays > 1000-fold selectivity over α-adrenoceptors, 5-HT, dopamine and muscarinic ACh receptors. Orally active antidepressant.

Compound Libraries

Reboxetine mesylate is also offered as part of the Tocriscreen Plus. Find out more about compound libraries available from Tocris.

Technical Data

M. Wt 409.5
Formula C19H23NO3.CH3SO3H
Storage Desiccate at +4°C
Purity ≥99% (HPLC)
CAS Number 98769-84-7
PubChem ID 76970698
InChI Key OEQQXKDUXVTKMH-BGLVZNNJSA-N
Smiles [H][C@]2(OCCNC2)[C@@H]([C@]3=CC=CC=C3)OC1=C(OCC)C=CC=C1.[H][C@@]5(OCCNC5)[C@H]([C@]6=CC=CC=C6)OC4=C(OCC)C=CC=C4.CS(=O)(O)=O.CS(=O)(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
water 20.48 50
DMSO 20.48 50

Preparing Stock Solutions

The following data is based on the product molecular weight 409.5. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 2.44 mL 12.21 mL 24.42 mL
5 mM 0.49 mL 2.44 mL 4.88 mL
10 mM 0.24 mL 1.22 mL 2.44 mL
50 mM 0.05 mL 0.24 mL 0.49 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets

Certificate of Analysis / Product Datasheet
Select another batch:
Safety Datasheet

References

References are publications that support the biological activity of the product.

Sacchetti et al (1999) Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br.J.Pharmacol. 128 1332 PMID: 10578149

Wong et al (2000) Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol.Psychiatry. 47 818 PMID: 10812041

Millan et al (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: I Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J.Pharmacol.Exp.Ther. 298 565 PMID: 11454918

Owen and Whitton (2003) Reboxetine modulates norepinephrine efflux in the frontal cortex of the freely moving rat: the involvement of α2 and 5-HT1A receptors. Neurosci.Lett. 348 171 PMID: 12932821


If you know of a relevant reference for Reboxetine mesylate, please let us know.

View Related Products by Product Action

View all Adrenergic Transporter Inhibitors

Keywords: Reboxetine mesylate, Reboxetine mesylate supplier, Potent, selective, noradrenalin, noradrenaline, reuptake, inhibitors, inhibits, orally, active, Transporters, NET, Adrenergic, adrenaline, adrenalin, Monoamine, Neurotransmitter, 1982, Tocris Bioscience

7 Citations for Reboxetine mesylate

Citations are publications that use Tocris products. Selected citations for Reboxetine mesylate include:

Hughes et al (2013) Endogenous analgesic action of the pontospinal noradrenergic system spatially restricts and temporally delays the progression of neuropathic pain following tibial nerve injury. Int J Neuropsychopharmacol 154 1680 PMID: 23707289

Hutchinson et al (2012) Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin. Pain 37 321 PMID: 21956448

Ferreira et al (2012) Presynaptic CB(1) cannabinoid receptors control frontocortical serotonin and glutamate release--species differences. Theriogenology 61 219 PMID: 22609378

Munari et al (2015) Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects. Neurochem Int 18 pyv045 PMID: 25899065

Suto et al (2014) Peripheral nerve injury and gabapentin, but not their combination, impair attentional behavior via direct effects on noradrenergic signaling in the brain. Pain 155 1935 PMID: 24837843

Stuart et al (2013) A translational rodent assay of affective biases in depression and antidepressant therapy. Neuropsychopharmacology 38 1625 PMID: 23503126

Kobayashi et al (2010) Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine. Neuropsychopharmacology 35 1560 PMID: 20393461


Do you know of a great paper that uses Reboxetine mesylate from Tocris? Please let us know.

Reviews for Reboxetine mesylate

Average Rating: 5 (Based on 1 Review.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Reboxetine mesylate?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Reboxetine mesysate effect in mice. Brain MCP-1.
By Anonymous on 01/10/2018
Assay Type: In Vivo
Species: Mouse

Reboxetine mesylate was dissolved in saline serum and 20 mg/kg (100 μL) were administered intraperitoneally to mice. After 24h, brain samples were taken and MCP-1 synthesis was analyzed by immunohistochemistry. This way, we confirmed that reboxetine treatment induces MCP-1 synthesis in cortical astrocytes.

In the figure, MCP-1 is labeled in red and GFAP in green.

review image

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cardiovascular

Cardiovascular Research Product Guide

A collection of over 250 products for cardiovascular research, the guide includes research tools for the study of:

  • Hypertension
  • Thrombosis and Hemostasis
  • Atherosclerosis
  • Myocardial Infarction
  • Ischemia/Reperfusion Injury
  • Arrhythmias
  • Heart Failure